| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communication |
1 From the Department of Animal and Nutritional Sciences, University of New Hampshire, Durham; the Department of Psychology, University of Georgia, Athens; the Department of Ophthalmology, University of Indiana Medical School, Indianapolis; and The Food and Beverage Products Division, The Procter and Gamble Company, Cincinnati.
2 Scientific contribution #2112 from the New Hampshire Agriculture Experiment Station. 3 Address reprint requests to J Curran-Celentano, Department of Animal and Nutritional Sciences, Kendall Hall, Durham, NH 03824. E-mail: joannec{at}christa.unh.edu.
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONSUBJECTS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Objective: This study was designed to evaluate the relation between dietary intake, blood concentrations, and retinal concentrations of carotenoids in a large group of volunteers.
Design: Two hundred eighty volunteers in the Indianapolis area completed health and diet questionnaires, donated a blood sample, and participated in MP density assessment to determine retinal carotenoid status. Dietary intake was assessed by food-frequency questionnaire. Serum concentrations of lutein, zeaxanthin, and ß-carotene were measured by HPLC. MP optical density (MPOD) was determined psychophysically with a 460-nm, 1° test stimulus.
Results: Average MPOD was 0.21 ± 0.13. Average intakes of lutein + zeaxanthin and ß-carotene were 1101 ± 838 and 2935 ± 2698 µg/d, respectively. Although several key dietary intake variables (eg, lutein + zeaxanthin and ß-carotene) differed by sex, no significant sex differences were found in either serum concentrations of lutein and zeaxanthin or MPOD. Serum ß-carotene concentrations were significantly higher in women than in men. Serum lutein + zeaxanthin and dietary intake of lutein + zeaxanthin were significantly correlated and significantly related to variations in MPOD (r = 0.21, P < 0.001, and r = 0.25, P < 0.001, respectively).
Conclusions: Retinal carotenoids can be measured in epidemiologic studies. In this study, MPOD was associated with lutein + zeaxanthin in the diet and the serum. Retinal concentrations, however, were influenced by other factors as well. To understand the effect of dietary lutein + zeaxanthin intake on the retina and risk of age-related eye disease, future studies should include measures of macular concentrations of these pigments.
Key Words: Retinal carotenoids • macular pigment • age-related macular degeneration • lutein • zeaxanthin • ß-carotene • macular pigment optical density
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONSUBJECTS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Another example is the finding that lutein and zeaxanthin, as measured in the diet (2) and in serum (7,8), are related to reduced risk of age-related macular degeneration. Lutein and zeaxanthin, to the exclusion of other carotenoids, are concentrated in the foveal pit of the human retina and when deposited in this region are referred to as macular pigment (MP) (9,10). The concentration of the MP carotenoids in human retina varies widely (11,12). Increased MP optical density (MPOD) has been linked directly to preserved foveal function in patients with annular maculopathy (13) and to preserved visual sensitivity in normal-aged subjects (14,15). This protection may be because MP is localized within the inner foveal layers and absorbs short-wave light before it can damage vulnerable lipid-rich membranes in the outer segments of photoreceptors. The identification of lutein and zeaxanthin oxidation products within the human retina supports the possibility that the pigments may also serve to deactivate reactive oxygen species often generated within the retina (16).
MPOD can be modified by increasing intake of lutein-rich foods or purified lutein and zeaxanthin supplements (17,18). Preliminary evidence suggests that lutein supplementation may improve symptoms of retinal degeneration in its earliest stages (19,20). This confluence of data suggests that individual differences in MPOD are meaningful. Because past epidemiologic work assessed the relation between risk of age-related macular degeneration and lutein and zeaxanthin measured in the diet and serum, the relation between MPOD and these variables is also of interest (21). Although normative values for serum concentrations and dietary intakes of carotenoids have been published, no large studies have measured normative values of MPOD and its relation to dietary intake and serum concentration of these pigments. Moreover, the question of whether MPOD can be measured effectively in a clinical research setting has not been addressed.
|
SUBJECTS AND METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONSUBJECTS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Subject evaluation
Subjects were asked to fast (only water and non-energy-containing beverages were allowed) for 
6 h before the planned blood draw. A core questionnaire that included questions on demographics, lifestyle, medical history, and health was completed by the subjects. The details of the questionnaire were reported previously (22); the information collected included data on medication use, nutritional supplementation, height and weight, smoking, and physical activity.
Assessment of macular pigment optical density
MPOD was measured with a psychophysical technique as described in Snodderly and Hammond (23). All MPOD measurements were made on the subjects' right eye. Subjects wore their own corrective lenses, or trial lenses, so that their near visual acuity was 20/25 or better during the test.
MPOD was measured with a 1° test stimulus. The 1° test stimulus was presented near the center of a 6°, 1.5 log trolands, 470-nm circular background. The test stimulus was alternately composed of a 460-nm measuring field (peak MP absorbance) and a 570-nm, 1.7 log trolands reference field (minimal MP absorbance). The troland values were calculated assuming a 3-mm pupil. The measuring and reference fields were superposed and presented out of phase at an alternation rate of 11–12 Hz in the foveal condition and 6–7 Hz in the parafoveal condition. Subjects adjusted the radiance of the 460-nm measuring field to achieve minimal flicker with the 570-nm reference field. This measurement was made in the fovea (where MP is the most dense) and 4° in the parafovea (where light absorption by MP is negligible). A tiny (5 min) opaque fixation point was located on the left edge of the background, and subjects fixated on this point when making the parafoveal measurement. Subtracting the foveal from the parafoveal sensitivity measurement yields a measure of MPOD. Subjects were given brief instructions on the method and a practice trial before 5 foveal and 5 parafoveal measurements were made. In a small portion of cases, either the foveal or parafoveal readings were repeated because the foveal readings had a range >100 units or the parafoveal readings had a range >75 units. The foveal and parafoveal values were calculated from the average of the final 5 readings, and these averages were then used to calculate the MPOD.
The apparatus used for the MP measurement delivered the stimulus in natural view, but used a stimulus configuration that was similar to configurations used in past studies in which the stimulus was presented in Maxwellian view (24–26). Recent evidence has shown, however, that MPOD measured in natural view, and with slight differences in stimulus configuration (eg, this study used a 4° rather than a 6° parafoveal reference), provides the same values as MPOD measured in Maxwellian view (27). Light for the 10° background was produced by 3 LEDs (packed tightly in a triangular array) with peak energy at 470 nm and half-widths of 
20 nm. Light for the 570-nm reference field was produced by an LED with peak energy at 570 nm (half-width = 20 nm). Light for the 460-nm measuring field was produced by 2 LEDs with peak energy at 458 nm (half-width = 20 nm). Light from the LED sources was collimated with planoconvex lenses and was then passed through polycarbonate diffusers (high-efficiency, holographic type; Physical Optics Co, Torrance, CA), which served essentially as back projection screens.
The size of the background and test stimulus was defined by circular apertures (constructed by computer-generated images exposed on high-density, photographic, oriented polyester film) placed after the collimating lenses. The background and test stimulus were then combined and reflected to the subject by a 5-cm (2-in) beam splitter whose front surface was located 41 cm (16 in) from the subject's eye. The entire optical system was contained in a rectangular, black thermoplastic box. One side of the box contained a 2.5-cm (1-in) hole centered on the subject's optical axis through which the stimulus could be viewed. The subject's head was aligned by using an adjustable head and chin rest assembly; when the head was properly aligned, the subject viewed the hole in the box as slightly larger and concentric with the background field.
Stimuli were calibrated by using a photocell (PIN-10; UDT Sensors, Inc, Hawthorne, CA). The LEDs were driven by a constant-current power supply. Radiance variation was achieved by varying the frequency of a 1.5-ms pulse over a range of 300–300000 Hz. Our calibration of the high-frequency pulse rate showed that the frequency delivery is nearly perfectly proportional to the radiance output. Thus, MPOD values could be derived by simply calculating the log ratio of the frequencies of the 460-nm measuring field at the foveal and parafoveal eccentricities, respectively.
Serum carotenoid assessment
Blood samples were collected into serum separator tubes and protected from direct light exposure during processing. Clotted blood was separated by centrifugation at 2000 x g at 4°C for 15 min. Serum was portioned into cryovials and shipped on dry ice to the University of New Hampshire, where it was stored at -80°C until analyzed.
Carotenoids were separated and quantified by reversed-phase HPLC. Serum was precipitated with ethanol containing the internal standard and was extracted into hexane. The extraction was repeated twice and the hexane layers from both extractions were removed to a common amber vial. The hexane was evaporated to dryness under a stream of nitrogen, the sample was resuspended in 200 µL ethanol, and 20 µL was injected by loop overfill for analysis. The serum was protected from light from the time of collection through analysis.
The reversed-phase gradient HPLC system was equipped with an HP 1100 (Hewlett-Packard, Burlington, MA) photo diode-array detector set at 292, 325, and 452 nm for tocopherol, retinol, and carotenoids, respectively. The analytic column was a 4.6 x 250 mm Bakerbond C18 column (Mallinckrodt Baker, Phillipsburg, NJ) following a Vydac (Western Analytic Products, Murietta, CA) high-performance 5-µm C18 guard column. The mobile phase consisted of 100% methanol buffered with 1% ammonium acetate with a flow rate of 1.5 mL/min that transitioned to methanol:methylene chloride (80:20, by vol) over the first 10 min and remained set for the remainder of the 15-min run before switching back to 100% methanol. The method allows for separation of lutein and zeaxanthin at 452 nm while maintaining a run time of 15 min. The method and data were stored by CHEMSTATION software (Hewlett-Packard HP 3365 Series II). Samples were quantified by using peak area ratios to internal standards and by simultaneously running lab standards and external standards. Analytic accuracy was assessed with use of the National Institutes of Standards and Technology (NIST; Gaithersburg, MD) Standard Reference Material SRM 986 and by participation in the NIST Micronutrients Measurement Quality Assurance Program.
Dietary consumption estimation
A 1-y food-frequency questionnaire was used to estimate the dietary consumption of lutein + zeaxanthin and other nutrients (28). The food-frequency questionnaire included questions about the usual intakes over the past year of 122 foods and food groups, as well as adjustment and summary questions (29). Also included was an addendum with questions about intake of regular, reduced-fat, fat-free, and olestra-containing savory snacks. The food-frequency questionnaires were processed at the Fred Hutchinson Cancer Research Center (Seattle), and average daily intakes of nutrients were determined by use of the center's database for average nutrient content of food categories, which was derived from the University of Minnesota Nutrition Coordinating Center nutrient database (Nutrition Coordinating Center, Minneapolis).
Statistical analysis
This study used a cross-sectional design to estimate the sample mean value of MPOD in a group of healthy adult volunteers. Before the start of the study, we performed power calculations that predicted that the study had sufficient power to detect a sample mean value within 5%, assuming an MPOD SD of 0.15 and a total of 275 subjects. For the final analysis, only one subject did not have a complete set of foveal and parafoveal readings, yielding 279 valid MPOD values. In addition, dietary consumption data were excluded for subjects reporting energy intakes <2090 or >20090 kJ/d, because such chronic intakes are not physiologically likely and indicate that the subject did not correctly complete the food-frequency questionnaire. This is a common practice in epidemiologic studies. Consequently, valid dietary consumption data were available for 278 subjects.
Several variables were assessed in these subjects: tobacco use; iris color; sex; serum concentrations of lutein and zeaxanthin; dietary lutein + zeaxanthin intake; race; refractive error; family history of age-related macular degeneration; pregnancy or lactation; vitamin E intake; serum ß-carotene; hours of sleep; age; dietary intake of fruit and vegetables, fat, iron, fiber, and olestra; use of supplements; visual acuity and ocular health; skin tone; use of prescription medications; body mass index; physical activity; and sun exposure. Values are reported as means ± SDs. For the present study, we limited our analysis of this data set to those variables that were relevant to the dietary habits of the participants. These variables, along with descriptive statistics, are listed in Table 1
. One exception was the analysis of olestra use and its relation to MPOD and serum carotenoid concentrations. These data are presented in Cooper et al (30). The analysis of variables relating to personal characteristics such as race, iris color, and refractive error is provided in a separate article by Pratt et al (31). The primary statistical analyses conducted were correlational (Pearson's r) and inferential (Student's t tests) to analyze mean differences. Analyses were performed with use of MICROCAL ORIGIN software (version 5.0; Microcal Software, Northampton, MA).
|
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONSUBJECTS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
. Almost one-half (45.4%) of the subjects were between the ages of 31 and 40 y. There were 138 men and 142 women. The ethnic distribution matched closely with regional demographics; 239 (85%) of the subjects were white. There were 150 nonsmokers, 58 former smokers, and 70 current smokers. According to body mass index, 53 (18.9%) of the subjects were overweight and 38 (13.6%) were obese (32).
Dietary intake, serum concentrations of carotenoids, and MPOD measurements are also summarized in Table 1. The distribution of MPOD within the sample is shown in Figure 1. Average MPOD did not differ significantly between the men (0.215 ± 0.13) and women (0.207 ± 0.13). This similarity in MPOD is surprising given the large disparity in dietary carotenoid intake. Women had 19% higher lutein + zeaxanthin intake (P < 0.01) and 23% higher ß-carotene intake (P < 0.05) than did the men, despite significantly (P < 0.0001) lower average fat (70.9 ± 38.9 compared with 103.4 ± 85.5 g/d) and energy (7654 ± 3296 compared with 10254 ± 2475 kJ/d) intakes.
|
). In fact, the current smokers had a slightly more carotenoid-dense diet overall than did the never and past smokers. To analyze whether smoking was directly related to serum carotenoid concentrations, the relation between smoking frequency (number of cigarettes smoked per day) and total carotenoid concentrations was analyzed. As shown in Figure 2, total carotenoids in serum were inversely related (r = –0.32, P < 0.005) to the number of cigarettes smoked per day by the current smokers in a dose-response manner. A significant dose-response relation was also found between serum lutein + zeaxanthin and smoking frequency (r = –0.26, P < 0.025). The relation between smoking frequency and carotenoid intake was not significant in current smokers.
|
|
). MPOD was significantly related to both serum lutein and zeaxanthin and dietary intake of lutein + zeaxanthin. The relation between MPOD and serum lutein, serum zeaxanthin, and dietary lutein + zeaxanthin is illustrated in Figures 3, 4 and 5, respectively. As shown in the figures, each covariate had a wide range; thus, although some associations were significant, variation made it impossible to generalize to individual cases. For example, one 38-y-old male nonsmoker with dark brown irises had a baseline serum lutein + zeaxanthin concentration of 1.02 µmol/L but an MPOD value of 0.03. Another 29-y-old male nonsmoker with light blue irises had a serum lutein + zeaxanthin concentration of 0.763 µmol/L but an MPOD of 0.045.
|
|
|
|
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONSUBJECTS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
We report on the MPOD of 280 subjects in the Midwest. The recruitment criteria excluded subjects associated with the local university or medical school to avoid possible selection bias. In previous reports, the average MPOD value when testing subjects from a Northeast population was 0.35 (37). Thus, the average MPOD of 0.21 seen in the Midwest population is 40% less than that seen in the Northeast. The average MPOD in the Midwest population is similar to that found in a Southwest population (38) tested by similar procedures (n = 217; average MPOD = 0.22 ± 0.13). There was a significant relation between MPOD and dietary lutein + zeaxanthin and serum lutein in each of the studies. It is interesting to note the similarity between our average serum and dietary carotenoid values and those taken from large random samples (7, 8, 39; Table 4). It is too early to suggest that serum or dietary carotenoid concentration can predict MPOD. However, because methods are now available to measure retinal carotenoids without the use of extensive optical systems (27), future studies should make use of such measurements to better understand the relation of dietary carotenoids to MP and to visual health.
|
We found no significant relation between smoking and MPOD. This result is consistent with the null effect of smoking on serum lutein and zeaxanthin concentrations in this sample (Table 2). This lack of effect may be due to the slightly more carotenoid-dense diet of the current smokers and the preponderance of light smokers in the study. Past studies have suggested that smoking <20 cigarettes/d does not have measurable effects on MPOD. This is consistent with the dose-response curve shown in Figure 2, in which heavier smoking had the greatest effect on serum carotenoid concentrations.
All the correlations must be viewed in light of the restricted range of MP values in this Midwest population. For example, the highest MP value in this sample was less than one-half of the highest value in Northeast samples that we have studied (37). The fact that significant correlations were found under these conditions suggests that the coefficients may underestimate the strength of the relation.
Whereas dietary lutein + zeaxanthin and serum lutein and zeaxanthin were significantly correlated with each other and with MPOD, the relations appeared to be less robust than predicted. Biological factors such as individual absorption profiles and day-to-day variation in blood concentrations contribute substantially to the attenuation of diet-serum correlations. Moreover, errors in measurement of dietary intake, serum carotenoid concentrations, and MPOD undoubtedly attenuate correlations. With the enhanced database information on dietary carotenoid values, improved methods for measuring the distribution of MP in a population-based study, and a better understanding of the transport and deposition of carotenoids in tissue, future studies should enhance our understanding of the links between diet, blood, and tissue concentrations and disease risk.
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONSUBJECTS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
-carotene, ß-carotene, and vitamin E in humans. Am J Clin Nutr 2000;71:1187–93.This article has been cited by other articles:
|
|
 |
|
  A. During, S. Doraiswamy, and E. H. Harrison Xanthophylls are preferentially taken up compared with {beta}-carotene by retinal cells via a SRBI-dependent mechanism J. Lipid Res., August 1, 2008; 49(8): 1715 - 1724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhao and B. V. Sweet Lutein and zeaxanthin for macular degeneration Am. J. Health Syst. Pharm., July 1, 2008; 65(13): 1232 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Iannaccone, M. Mura, K. T. Gallaher, E. J. Johnson, W. A. Todd, E. Kenyon, T. L. Harris, T. Harris, S. Satterfield, K. C. Johnson, et al. Macular Pigment Optical Density in the Elderly: Findings in a Large Biracial Midsouth Population Sample Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1458 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Waters, R. M. Clark, C. M. Greene, J. H. Contois, and M. L. Fernandez Change in Plasma Lutein after Egg Consumption Is Positively Associated with Plasma Cholesterol and Lipoprotein Size but Negatively Correlated with Body Size in Postmenopausal Women J. Nutr., April 1, 2007; 137(4): 959 - 963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Aleman, A. V. Cideciyan, E. A. M. Windsor, S. B. Schwartz, M. Swider, J. D. Chico, A. Sumaroka, A. Y. Pantelyat, K. G. Duncan, L. M. Gardner, et al. Macular Pigment and Lutein Supplementation in ABCA4-Associated Retinal Degenerations Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1319 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Nolan, J. Stack, E. O'Connell, and S. Beatty The Relationships between Macular Pigment Optical Density and Its Constituent Carotenoids in Diet and Serum Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 571 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Dixon, A. F. Subar, L. Wideroff, F. E. Thompson, L. L. Kahle, and N. Potischman Carotenoid and Tocopherol Estimates from the NCI Diet History Questionnaire Are Valid Compared with Multiple Recalls and Serum Biomarkers J. Nutr., December 1, 2006; 136(12): 3054 - 3061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R Trumbo and K. C Ellwood Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration's evidence-based review system for health claims. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 971 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A Mares, T. L LaRowe, D M. Snodderly, S. M Moeller, M. J Gruber, M. L Klein, B. R Wooten, E. J Johnson, R. J Chappell, and for the CAREDS Macular Pigment Study Group and Inv Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1107 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. F. Goodrow, T. A. Wilson, S. C. Houde, R. Vishwanathan, P. A. Scollin, G. Handelman, and R. J. Nicolosi Consumption of One Egg Per Day Increases Serum Lutein and Zeaxanthin Concentrations in Older Adults without Altering Serum Lipid and Lipoprotein Cholesterol Concentrations J. Nutr., October 1, 2006; 136(10): 2519 - 2524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Whitehead, J. A. Mares, and R. P. Danis Macular Pigment: A Review of Current Knowledge Arch Ophthalmol, July 1, 2006; 124(7): 1038 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. M. Liew, C. E. Gilbert, T. D. Spector, J. Mellerio, J. Marshall, F. J. van Kuijk, S. Beatty, F. Fitzke, and C. J. Hammond Heritability of Macular Pigment: A Twin Study Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4430 - 4436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Burke, J. Curran-Celentano, and A. J. Wenzel Diet and Serum Carotenoid Concentrations Affect Macular Pigment Optical Density in Adults 45 Years and Older J. Nutr., May 1, 2005; 135(5): 1208 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Ribaya-Mercado and J. B. Blumberg Lutein and Zeaxanthin and Their Potential Roles in Disease Prevention J. Am. Coll. Nutr., December 1, 2004; 23(suppl_6): 567S - 587S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hercberg, P. Galan, P. Preziosi, S. Bertrais, L. Mennen, D. Malvy, A.-M. Roussel, A. Favier, and S. Briancon The SU.VI.MAX Study: A Randomized, Placebo-Controlled Trial of the Health Effects of Antioxidant Vitamins and Minerals Arch Intern Med, November 22, 2004; 164(21): 2335 - 2342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Neuringer, M. M. Sandstrom, E. J. Johnson, and D. M. Snodderly Nutritional Manipulation of Primate Retinas, I: Effects of Lutein or Zeaxanthin Supplements on Serum and Macular Pigment in Xanthophyll-Free Rhesus Monkeys Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3234 - 3243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chitchumroonchokchai, S. J. Schwartz, and M. L. Failla Assessment of Lutein Bioavailability from Meals and a Supplement Using Simulated Digestion and Caco-2 Human Intestinal Cells J. Nutr., September 1, 2004; 134(9): 2280 - 2286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schupp, E. Olano-Martin, C. Gerth, B. M Morrissey, C. E Cross, and J. S Werner Lutein, zeaxanthin, macular pigment, and visual function in adult cystic fibrosis patients Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1045 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Nelson, P. S. Bernstein, M. C. Schmidt, M. S. Von Tress, and E. W. Askew Dietary Modification and Moderate Antioxidant Supplementation Differentially Affect Serum Carotenoids, Antioxidant Levels and Markers of Oxidative Stress in Older Humans J. Nutr., October 1, 2003; 133(10): 3117 - 3123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T. J. M. Berendschot, J. J. M. Willemse-Assink, M. Bastiaanse, P. T. V. M. de Jong, and D. van Norren Macular Pigment and Melanin in Age-Related Maculopathy in a General Population Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1928 - 1932. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||
; n = 138) and women (
; n = 142).
